Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ · Healthcare
Recursion Pharmaceuticals, Inc. Shareholder Equity 2019–2025
Recursion Pharmaceuticals, Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Recursion Pharmaceuticals, Inc. shareholder equity as of December 31, 2025: 1.13B, a 9.29% increase year-over-year.
- Recursion Pharmaceuticals, Inc. shareholder equity for 2025 were 1.13B, a 9.29% increase from 2024.
- Recursion Pharmaceuticals, Inc. shareholder equity for 2024 were 1.03B, a 123.28% increase from 2023.
- Recursion Pharmaceuticals, Inc. shareholder equity for 2023 were 463.4M, a 4.60% decrease from 2022.
- Recursion Pharmaceuticals, Inc. shareholder equity for 2022 were 485.8M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Recursion Pharmaceuticals, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $1,131 |
| 2024 | $1,035 |
| 2023 | $463 |
| 2022 | $486 |
| 2021 | $543 |
| 2020 | $-206 |
Recursion Pharmaceuticals, Inc. Shareholder Equity — FAQ
Recursion Pharmaceuticals, Inc. (RXRX) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RXRX's shareholder equity history?
The chart and table above show Recursion Pharmaceuticals, Inc.'s shareholder equity by year and by quarter, including the growth rate.